Advances in access to clinical genetic testing have significantly reduced the average age of diagnosis of many neurodevelopmental disorders, however, PTHS is not yet included in newborn screening panels (Kernohan & Boycott, 2024; Zhang et al., 2024). This evidence concerns the gene TCF4 and neurodevelopmental disorder.